All links below open in a new browser tab or window.
Official Periodical of The International Academy of Cytology which provides state-of-the-art information on research, medical developments and practical techniques for the busy practitioner.
Quality Assurance aims to maintain minimum standards while encouraging the continued striving for excellence. The process of quality assurance ensures the quality systems are in place and that set standards are met.
NHS Cancer Screening Programme
The cancer screening programmes of England are nationally coordinated. They are the NHS Breast Screening Programme, the NHS Cervical Screening Programme and the NHS Bowel Cancer Screening Programme.
The organization’s main objects, as formulated in Art. 3 of the statutes are to promote professional training of both medical and non-medical cytologists and to promote the status and eminence of cytology.
In order to promote high quality of cytodiagnosis the organization may set standards for certification of professionals and laboratories as far as such standards have not been set by national bodies.
Continuing education may be advanced through the organization of workshops, tutorials and congresses.
The Department of Health (DH) exists to improve the health and wellbeing of people in England.
The statutory regulator that works to protect the health and well-being.
The IBMS is the professional body for biomedical scientists in the United Kingdom. It aims to
promote and develop the role of biomedical science within healthcare to deliver the best possible service for patient care and safety.
The International Academy of Cytology is a scientific, non-profit organization of cytopathologists,
cytotechnologists and other professionals concerned with research in and practice of clinical cytology. It was founded in 1957.
The website aims to further public education and promote study and research. The pages include details of
examinations, courses, meetings and research.
Formed by the merger of the BSCC and the NAC. The BAC is a new association, and a huge opportunity for all
professional groups in cytology to work together. We have a new executive, several of whom who will be contributing to this publication; there is much to do.
The Society, founded in 1972, represents a common forum for the discussion and debate of all matters pertaining to the prevention of cancer of the cervix. By its very nature the Society is multidisciplinary, a fact that almost certainly explains its strengths and continued growth. Most, if not all, members find membership, and particularly attendance at the annual meeting, a major influence in
their practice and a key feature of their postgraduate education. Change affects all branches of healthcare and cervical disease is no exception.